Page 3 - Nyse Rdy News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nyse rdy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nyse Rdy Today - Breaking & Trending Today
Greenleaf Trust lowered its holdings in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 1.2% during the third quarter, HoldingsChannel.com reports. The firm owned 23,499 shares of the company’s stock after selling 290 shares during the period. Greenleaf Trust’s holdings in Dr. Reddy’s Laboratories were worth $1,571,000 at the end of the […] ....
KLR Investment Advisors LLC purchased a new position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 6,605 shares of the company’s stock, valued at approximately $442,000. A number of other large investors have also […] ....
Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) issued its earnings results on Wednesday. The company reported $0.99 EPS for the quarter, beating the consensus estimate of $0.88 by $0.11, MarketWatch Earnings reports. Dr. Reddy’s Laboratories had a return on equity of 20.97% and a net margin of 19.26%. The business had revenue of $867.00 […] ....
Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) issued its earnings results on Wednesday. The company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.88 by $0.11, MarketWatch Earnings reports. The business had revenue of $867.00 million for the quarter, compared to the consensus estimate of $827.81 million. Dr. Reddy’s Laboratories had […] ....
Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.88 by $0.11, MarketWatch Earnings reports. The company had revenue of $867.00 million for the quarter, compared to analyst estimates of $827.81 million. Dr. Reddy’s […] ....